Skip to content

DrCastermansA: what changed

BE 0789.224.365NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€142,120
2024 · €115,511+€26,609
Equity
€5,000
2024 · €202,589-€197,589
Cash
€76,221
2024 · €144,154-€67,933
Balance sheet total
€353,926
2024 · €206,377+€147,549

Largest movements

2024 to 2025
Assets
  • Current investments +€200,000

    first reported in 2025, at €200,000

  • Cash -€67,933

    down €67,933 (-47.1%), from €144,154 to €76,221

    mainly Contributions, distributions and other (-€339,709) and Current investments (-€200,000)

  • Deferred charges and accrued income +€12,518

    up €12,518 (+21.9%), from €57,157 to €69,675

  • Receivables within one year +€3,700

    first reported in 2025, at €3,700

Equity and liabilities
  • Other debts +€338,126

    up €338,126 (+20,368%), from €1,660 to €339,786

  • Profit (loss) carried forward -€197,589

    no longer reported in 2025; in 2024 it stood at €197,589

  • Tax, wage and social debts +€5,569

    up €5,569 (+290%), from €1,922 to €7,491

Income statement
  • Gross operating margin +€36,355

    up €36,355 (+24.2%), from €150,352 to €186,707

  • Taxes +€9,569

    up €9,569 (+29.1%), from €32,922 to €42,491

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €115,511
Gross operating margin +€36,355
Depreciation -€154
Other operating charges -€73
Financial income +€53
Financial charges -€2
Taxes -€9,569
Result 2025 €142,120
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€472,745
Investment -€200,969
Financing -€339,709
Cash 2024 €144,154
Net result for the year +€142,120
Depreciation +€1,705
Receivables within one year -€3,700
Deferred charges and accrued income -€12,518
Trade debts +€1,444
Tax, wage and social debts +€5,569
Other debts +€338,126
Investment in fixed assets (net) -€969
Current investments -€200,000
Contributions, distributions and other -€339,709
Cash 2025 €76,221
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €206,377 €353,926 +€147,549 +71.5%
Fixed assets 21/28 €5,066 €4,330 -€736 -14.5%
Tangible fixed assets 22/27 €5,066 €4,330 -€736 -14.5%
Plant, machinery and equipment 23 €1,386 €1,699 +€313 +22.6%
Furniture and vehicles 24 €3,680 €2,632 -€1,049 -28.5%
Current assets 29/58 €201,311 €349,596 +€148,285 +73.7%
Amounts receivable within one year 40/41 - €3,700 +€3,700
Trade receivables 40 - €3,700 +€3,700
Current investments 50/53 - €200,000 +€200,000
Cash at bank and in hand 54/58 €144,154 €76,221 -€67,933 -47.1%
Deferred charges and accrued income 490/1 €57,157 €69,675 +€12,518 +21.9%
Total equity and liabilities 10/49 €206,377 €353,926 +€147,549 +71.5%
Equity 10/15 €202,589 €5,000 -€197,589 -97.5%
Contributions 10/11 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 €197,589 - -€197,589
Amounts payable 17/49 €3,787 €348,926 +€345,138 +9,113%
Amounts payable within one year 42/48 €3,787 €348,926 +€345,138 +9,113%
Trade debts 44 €205 €1,649 +€1,444 +703%
Suppliers 440/4 €205 €1,649 +€1,444 +703%
Taxes, remuneration and social security 45 €1,922 €7,491 +€5,569 +290%
Taxes 450/3 €1,922 €7,491 +€5,569 +290%
Other amounts payable 47/48 €1,660 €339,786 +€338,126 +20,368%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,551 €1,705 +€154 +9.9%
Other operating charges 640/8 €326 €400 +€73 +22.5%
Gross operating margin 9900 €150,352 €186,707 +€36,355 +24.2%
Operating profit (loss) 9901 €148,476 €184,603 +€36,127 +24.3%
Financial income 75/76B - €53 +€53
Recurring financial income 75 - €53 +€53
Financial charges 65/66B €43 €45 +€2 +4.7%
Recurring financial charges 65 €43 €45 +€2 +4.7%
Profit (loss) for the period before taxes 9903 €148,433 €184,610 +€36,178 +24.4%
Income taxes 67/77 €32,922 €42,491 +€9,569 +29.1%
Profit (loss) for the period 9904 €115,511 €142,120 +€26,609 +23.0%
Profit (loss) for the period to be appropriated 9905 €115,511 €142,120 +€26,609 +23.0%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€405,607 to €566,850

Midpoint €472,792 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €5,000
Capitalised earnings €806,214 to €1.1m
Indication €405,607 to €566,850

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€5,000
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€5,000

Capitalised earnings

net result for the year (9904)
2025
€142,120
2024
€115,511
2023
€80,981
2022
€3,590
Average result
€112,870
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€806,214 / €940,583 / €1.1m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.